🔎 Trials Near Me

Beranda › Kanker Payudara › Texas › Lubbock

Uji klinis Kanker Payudara di Lubbock, TX

6 studi untuk Kanker Payudara mencari peserta di lokasi sekitar Lubbock (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Menerima pesertaFase 3
  • Texas Tech University Health Sciences Center ( Site 0087), Lubbock
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06966700

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Menerima pesertaFase 3
  • Covenant Children's Hospital- Joe Arrington Cancer Research and Treatment Center, Lubbock
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06492616

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Menerima pesertaFase 3
  • UMC Cancer Center / UMC Health System, Lubbock
  • Texas Tech University Health Sciences Center-Lubbock, Lubbock
Usia 18 hingga 60 · Wanita · Diperbarui 2 Sep 2026 · NCT05879926

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Menerima pesertaFase 3
  • UMC Cancer Center / UMC Health System, Lubbock
  • Texas Tech University Health Sciences Center-Lubbock, Lubbock
Usia 50 hingga 70 · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT04852887

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Menerima pesertaStudi observasional
  • Joe Arrington Cancer Research & Treatment Center, Lubbock
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Jan 2026 · NCT06401421

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Menerima pesertaStudi observasional
  • Texas Tech UHSC - Southwest Cancer Center, Lubbock
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2025 · NCT03053193

Uji klinis Kanker Payudara di kota lain

Studi lain di Lubbock

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.